Company intelligence / Profile preview
Thermosome
Planegg/Martinsried, Bavaria, Germanythermosome.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Initial clinical data from the ongoing Phase I trial of THE001 show encouraging safety and early signs of efficacy. No renal or cardiac impairment or formulation-related adverse events were observed; no patients discontinued due to adverse events. The approach achieves up to a 15-fold increase in local tumor drug concentration with a favorable pharmacokinetic profile compared to conventional doxorubicin.[2] The company has initiated the final dose level in its Phase I trial as of early 2024.[1] European Orphan Drug Designation granted for STS.[5]
- Therapeutic areas
- Oncology
- Modalities
- Thermosensitive liposomal drug delivery (TSL)Small molecules (doxorubicin)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
IMAGIO Consortium participation to improve cancer treatment
Beyond the preview
Go deeper on Thermosome.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thermosome.